The role of microbiota in liver diseases

Recruiting

• Conditions: K83.0; K83.1; K83.8; K83.9; K87.0; Cholangitis; Obstruction of bile duct; Other specified diseases of biliary tract; Disease of biliary tract, unspecified; Disorders of gallbladder and biliary tract in diseases classified elsewhere

• Registration Number: DRKS00010513
• Lead Sponsor: Medizinische Hochschule Hannover

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-08-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

bile-duct associated liver diseases

Exclusion Criteria

Unable to give consent
Pregnany

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Analyzation of changes in composition and<br>distribution of the microbiome with NGS (Next Generation Sequencing) in patients with liver disease, compared to a healthy control group during in-hospitalization.

Secondary Outcome Measures

Name	Time	Method
Analysis of microbial diversity, depending on the underlying liver disease